➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Merck
Colorcon
Dow
Harvard Business School
Moodys

Last Updated: July 9, 2020

DrugPatentWatch Database Preview

Details for Biologics License Application: 022575


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for BLA: 022575
Tradename:VPRIV
Applicant:Shire Human Genetic
Ingredient:velaglucerase alfa
Patents:5
Approval Date:Feb 26, 2010
Suppliers: see list1

US Patents for BLA: 022575

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Shire Human Genetic VPRIV velaglucerase alfa INJECTABLE;INTRAVENOUS 022575 001 2010-02-26   Start Trial 2036-02-11 DISCN Orphan search
Shire Human Genetic VPRIV velaglucerase alfa INJECTABLE;INTRAVENOUS 022575 001 2010-02-26   Start Trial Selecta Biosciences, Inc. (Watertown, MA) 2033-05-03 DISCN Orphan search
Shire Human Genetic VPRIV velaglucerase alfa INJECTABLE;INTRAVENOUS 022575 001 2010-02-26   Start Trial Children\'s Hospital Medical Center (Cincinnati, OH) 2037-02-14 DISCN Orphan search
Shire Human Genetic VPRIV velaglucerase alfa INJECTABLE;INTRAVENOUS 022575 001 2010-02-26   Start Trial 2039-02-26 DISCN Orphan search
Shire Human Genetic VPRIV velaglucerase alfa INJECTABLE;INTRAVENOUS 022575 001 2010-02-26   Start Trial 2039-02-26 DISCN Orphan search
Shire Human Genetic VPRIV velaglucerase alfa POWDER;INTRAVENOUS 022575 002 2010-02-26   Start Trial 2036-02-11 DISCN Orphan search
Shire Human Genetic VPRIV velaglucerase alfa POWDER;INTRAVENOUS 022575 002 2010-02-26   Start Trial Selecta Biosciences, Inc. (Watertown, MA) 2033-05-03 DISCN Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
McKesson
Mallinckrodt
Moodys
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.